Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2026-04-11 @ 3:04 AM
Study NCT ID:
NCT02063958
Status:
COMPLETED
Last Update Posted:
2018-07-30
First Post:
2014-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Pharmacology of SNX-5422 Plus Everolimus in Subjects With Neuroendocrine Tumors
Sponsor:
Esanex Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SNX5422-CLN-009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None